The relevance of working remotely instead of being at the workplace has never been greater than now. As you may know, several companies around the world have operated during the pandemic with employees performing their jobs from home. While this is a convenient mode of working, the number of cyber-security threats have also risen in recent years. One problem of remote work operations is that an organisation’s cybersecurity frameworks are not available when employees are working from home.
Accomplished cyber-attackers create newer online threats relentlessly. As companies have increasingly digitised their operations and storage databases, their sensitive data is vulnerable to such threats. This is where effective data security in Identity and Access Management (IAM) enters the fray. Currently, many organisations secure their access and identity systems in one conventional way or another.
The ongoing coronavirus pandemic exerts pressure on healthcare workers and hospitals around the world to an almost unfair degree. Any medical centre near you has most likely been working at full capacity for several months now. Advanced healthcare technology continues to be instrumental in saving many lives during this challenging phase and similar others.
In the last ten years, we’ve witnessed a dramatic rise in the number of novel disease outbreaks globally. Leading pharmaceutical companies have been working rigorously to develop newer drugs to effectively counter these threats. The relentless pressure to innovate and produce medicines has pushed major drug companies to embrace digital technology. And as the pharma industry moves towards complete digitalisation, the shadow of cyber threats now looms larger than ever. This is evident from the startling levels of sophistication in cybercrimes this millennium has seen already.